Webinar – Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong
Dr Daniel Lee of the Chinese University of Hong Kong, introduced the first ATP GMP facility in Hong Kong to our members.
粵港澳大灣區醫藥發展線上培訓課程2020
粵港澳大灣區發展是行政長官2020年度《施政報告》的一大重點。為幫助會員掌握發展機遇,香港科研製藥聯會在11月及12月與深圳醫院管理者協會合辦了有關粵港澳大灣區醫藥發展的線上培訓課程。
法規培訓:產品生命周期管理
約60名來自會員公司及學術界的來賓,參與了由香港大學及本會共同舉辦的產業生命周期管理法規培訓課程。(請參閱英文版本)
About 60 members, non-members and academics turned up for Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop jointly organized by The University of Hong Kong and HKAPI.
Regulatory Training Programme Course 4 (Pharmacovigilance)
85 members, non-members and academics turned up for Regulatory Training Programme Course 4 – the last core course of the Programme which is jointly organized by The University of Hong Kong and HKAPI.
法規培訓課程第六課(臨床試驗)
The sixth course of the Regulatory Training Programme, that is jointly organized by the University of Hong Kong and HKAPI, was attended by 75 members and academics.
First Joint Forum in Macau (Regulatory Training Programme C5)
A forum on the current development and future of Macao’s pharmaceutical sector was recently held at the University of Macao (UM) Wu Yee Sun Library. The event was co-organised by UM’s Institute of Chinese Medical Sciences, the Pharmaceutical Society of Macao, and the University of Hong Kong (HKU) Li Ka Shing Faculty of Medicine.
Regulatory Training Programme Course 3 (Drug Registration)
On March 27th, over 90 members showed up for the half-day training on the legal regulatory compliance of pharmaceutical business in Hong Kong.